News - NeuroTechnology Investors

Portfolio Company News

January 15, 2025

Radical Catheter Technologies’ 8F Neurovascular Catheter Receives US FDA 510(k) Clearance, Second for the Best-in-Class Ribbon Technology Platform

January 9, 2025

Kaneka Acquires EndoStream Medical Ltd.

December 12, 2024

Philips strengthens strategic partnership with Sim&Cure to expand innovation in neurovascular therapy

November 15, 2024

FreeOx’s Ox-01 to be Evaluated as Adjunct Mechanical Thrombectomy Therapy for Stroke in NINDS-Funded Phase 2/3 Clinical Trial on Stroke-dedicated STEP Platform

October 8, 2024

Borvo Medical Announces U.S. FDA 510(k) Clearance for Innovative Surgical Device, Offering a Minimally Invasive Option for Surgical Brain Treatment

September 30, 2024

Synchron Announces Positive Results from U.S. COMMAND Study of Endovascular Brain-Computer Interface

July 25, 2024

Radical presents initial data on recently US FDA-cleared catheter technology at SNIS 2024

July 22, 2024

Radical^TM Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery (SNIS) 21st Annual Meeting

April 16, 2024

First device in Japan designed exclusively for a radial artery puncture approach launched by Medtronic Japan

April 8, 2024

Exclusive: Synchron, a rival to Musk’s Neuralink, readies large-scale brain implant trial

April 8, 2024

Synchron Launches Patient Registry for Stentrode Brain Computer Interface

April 7, 2024

The ‘black sheep’ brain chip start-up backed by Bezos and Gates

Not a physician?

Invest in the future of neurotechnology through our partner fund

© 2025 NeuroTechnology Investors (NTI)

By registering with NTI, or otherwise using the Services or viewing content made available solely to registered users of the NTI Site in any way (all of which is “Confidential Information”), you agree to maintain the confidentiality of that Confidential Information and will not republish any Confidential Information you acquire through the NTI Site.

By using these Services, you also confirm that you have read and agree to our privacy policy and terms of use.